TrialBMJ open2022

Oral diazoxide versus placebo for severe or recurrent neonatal hypoglycaemia: Neonatal Glucose Care Optimisation (NeoGluCO) study - a randomised controlled trial.

Don Laing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.